查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1538540

自注射注射藥物市場報告：2030 年趨勢、預測與競爭分析

Self-Administered Parenteral Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

自行注射藥物的趨勢和預測

預計 2024 年至 2030 年，全球自行給藥注射藥物市場將以 5.5% 的複合年成長率成長。該市場的主要驅動力是特種藥物和生技藥品的重要性日益增加、家庭治療方案的接受度不斷提高以及智慧注射工具的使用不斷增加。全球自行注射藥物市場的未來充滿希望，心血管疾病、糖尿病、骨質疏鬆症、疼痛管理和荷爾蒙替代市場充滿機會。

自行注射藥物細分

該研究包括按產品類型、用途、分銷管道、應用和地區對全球自行給藥注射藥物的預測。

自行給藥注射藥物市場洞察

Lucintel 預測，由於對實用和安全的給藥系統的需求不斷增加，預填充式注射器將在預測期內實現最高成長。

在這個市場中，疼痛管理預計將在預測期內實現最高成長。

預計亞太地區在預測期內將出現最高成長。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球自行注射藥物市場預計將以5.5%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 該市場的主要驅動力是特種藥物和生技藥品的重要性日益增加、家庭治療方案的接受度不斷提高以及智慧注射工具的使用不斷增加。

Q3.市場的主要細分市場是：

A3. 自用注射藥物市場前景廣闊，在心血管疾病、糖尿病、骨質疏鬆症、疼痛管理和荷爾蒙替代市場方面存在機會。

Q4.市場的主要企業是：

A4. 一些主要企業如下：

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預測，由於對實用和安全的給藥系統的需求不斷增加，預填充式注射器預計將在預測期內實現最高成長。

Q6.未來五年預計哪些地區的市場成長最大？

A6.APAC 預計在預測期內成長最快。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球自行注射藥物市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球自行注射藥物市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品類型分類的全球自行給藥注射藥物市場
    • 預填充式注射器
    • 自動注射器
    • 筆式注射器
    • 其他
  • 按使用方法分類的全球自行給藥注射藥物市場
    • 一次性的
    • 可重複使用的
  • 按分銷管道分類的全球自行給藥注射藥物市場
    • 醫院藥房
    • 網路藥房
    • 居家醫療提供者
    • 專科診所
    • 其他
  • 全球自行給藥注射藥物市場（依應用）
    • 心血管疾病
    • 糖尿病
    • 骨質疏鬆症
    • 疼痛管理
    • 荷爾蒙補充療法
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球自用注射藥物市場區域分佈
  • 北美自行給藥注射藥物市場
  • 歐洲自行注射藥物市場
  • 亞太地區自行給藥注射藥物市場
  • 其他區域自行注射藥物市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球自行給藥注射藥物市場成長機會
    • 全球自行給藥注射藥物市場成長機會（依使用方法）
    • 全球自行給藥注射藥物市場成長機會（依分銷管道）
    • 全球自行給藥注射藥物市場成長機會（依應用）
    • 按地區分類的全球自行給藥注射藥物市場成長機會
  • 全球自行注射藥物市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球自行給藥注射藥物市場的產能
    • 全球自行給藥注射藥物市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections
簡介目錄

Self-Administered Parenteral Trends and Forecast

The future of the global self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets. The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Self-Administered Parenteral by Segment

The study includes a forecast for the global self-administered parenteral by product type, usage, distribution channel, application, and region.

Self-Administered Parenteral Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Pre-Filled Syringes
  • Auto injectors
  • Pen Injectors
  • Others

Self-Administered Parenteral Market by Usage [Shipment Analysis by Value from 2018 to 2030]:

  • Disposable
  • Reusable

Self-Administered Parenteral Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Online Pharmacies
  • Home Healthcare Providers
  • Specialty Clinics
  • Others

Self-Administered Parenteral Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiovascular Diseases
  • Diabetes
  • Osteoporosis
  • Pain Management
  • Hormone Replacement
  • Others

Self-Administered Parenteral Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Self-Administered Parenteral Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies self-administered parenteral companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the self-administered parenteral companies profiled in this report include-

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections

Self-Administered Parenteral Market Insights

Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.

Within this market, pain management is expected to witness the highest growth over the forecast period.

APAC is expected to witness the highest growth over the forecast period.

Features of the Global Self-Administered Parenteral Market

Market Size Estimates: Self-administered parenteral market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Self-administered parenteral market size by various segments, such as by product type, usage, distribution channel, application, and region in terms of value ($B).

Regional Analysis: Self-administered parenteral market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, usages, distribution channels, applications, and regions for the self-administered parenteral market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the self-administered parenteral market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for self-administered parenteral market?

Answer: The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the self-administered parenteral market?

Answer: The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.

Q3. What are the major segments for self-administered parenteral market?

Answer: The future of the self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets.

Q4. Who are the key self-administered parenteral market companies?

Answer: Some of the key self-administered parenteral companies are as follows:

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections

Q5. Which self-administered parenteral market segment will be the largest in future?

Answer: Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.

Q6. In self-administered parenteral market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness the highest growth over the forecast period.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the self-administered parenteral market by product type (pre-filled syringes, auto injectors, pen injectors, and others), usage (disposable and reusable), distribution channel (hospital pharmacies, online pharmacies, home healthcare providers, specialty clinics, and others), application (cardiovascular diseases, diabetes, osteoporosis, pain management, hormone replacement, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Self-Administered Parenteral Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Self-Administered Parenteral Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Self-Administered Parenteral Market by Product Type
    • 3.3.1: Pre-Filled Syringes
    • 3.3.2: Auto injectors
    • 3.3.3: Pen Injectors
    • 3.3.4: Others
  • 3.4: Global Self-Administered Parenteral Market by Usage
    • 3.4.1: Disposable
    • 3.4.2: Reusable
  • 3.5: Global Self-Administered Parenteral Market by Distribution Channel
    • 3.5.1: Hospital Pharmacies
    • 3.5.2: Online Pharmacies
    • 3.5.3: Home Healthcare Providers
    • 3.5.4: Specialty Clinics
    • 3.5.5: Others
  • 3.6: Global Self-Administered Parenteral Market by Application
    • 3.6.1: Cardiovascular Diseases
    • 3.6.2: Diabetes
    • 3.6.3: Osteoporosis
    • 3.6.4: Pain Management
    • 3.6.5: Hormone Replacement
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Self-Administered Parenteral Market by Region
  • 4.2: North American Self-Administered Parenteral Market
    • 4.2.1: North American Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.2.2: North American Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
  • 4.3: European Self-Administered Parenteral Market
    • 4.3.1: European Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.3.2: European Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
  • 4.4: APAC Self-Administered Parenteral Market
    • 4.4.1: APAC Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.4.2: APAC Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
  • 4.5: ROW Self-Administered Parenteral Market
    • 4.5.1: ROW Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.5.2: ROW Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Self-Administered Parenteral Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Self-Administered Parenteral Market by Usage
    • 6.1.3: Growth Opportunities for the Global Self-Administered Parenteral Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Self-Administered Parenteral Market by Application
    • 6.1.5: Growth Opportunities for the Global Self-Administered Parenteral Market by Region
  • 6.2: Emerging Trends in the Global Self-Administered Parenteral Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Self-Administered Parenteral Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Self-Administered Parenteral Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Becton, Dickinson and Company
  • 7.2: scPharmaceuticals
  • 7.3: Harro Hofliger
  • 7.4: Owen Mumford
  • 7.5: Haselmeier
  • 7.6: Stevanato Group
  • 7.7: Ypsomed AG
  • 7.8: Solteam Group
  • 7.9: AstraZeneca
  • 7.10: Enable Injections